[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsSecond Intervention group: Receiving Interferon-beta 1A (Sinagen Pharmaceutical Company) with a dose of 12 million units of subcutaneous injection every other day + Remdesivir (Ronak Pharmaceutical Company) with a loading dose of 200 mg on the first day and then a dose of 100 mg daily Intravenously for 7-14 days based on the patient's clinical condition in addition to standard treatment according to national guidelines, (Which includes corticosteroids (dexamethasone or methylprednisolone) and anticoagulants (heparin or enoxaparin).)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsFirst intervention group: Receiving Remdesivir (Ronak Daru Pharmaceutical Company) with a loading dose of 200 mg on the first day and then a daily dose of 100 mg by intravenous injection for 7-14 days depending on the patient's clinical condition in addition to standard treatment according to national guidelines, (Which includes corticosteroids (dexamethasone or methylprednisolone) and anticoagulants (heparin or enoxaparin).)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 671, "treatment_name": "Interferon beta 1a", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}]